Research ExplorerScientific StaffChristoffer Gebhardt Publications

Univ. Prof. Dr. ID: 5526253

Christoffer Gebhardt

graph of relations
Affiliations
Links
ORCID: 0000-0001-7090-9584
1 - 50 out of 106Page size: 50

Publications

  1. 2024

  2. Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanoma

    Geidel, G., Parnian, N., Meß, C., Schlepper, N., Rünger, A., Heidrich, I., Hansen, I., Smit, D. J., Menz, A., Pantel, K., Schneider, S. W., Kött, J. & Gebhardt, C., 10.2024, In: J EUR ACAD DERMATOL. 38, 10, p. 2017-2023 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma

    Kött, J., Zimmermann, N., Zell, T., Heidrich, I., Geidel, G., Rünger, A., Smit, D. J., Merkle, M., Parnian, N., Hansen, I., Hoehne, I., Abeck, F., Torster, L., Weichenthal, M., Pantel, K., Schneider, S. W. & Gebhardt, C., 08.2024, In: J EUR ACAD DERMATOL. 38, 8, p. 1575–1587 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study: Addendum

    Bai, X., Shaheen, A., Grieco, C., d'Arienzo, P. D., Mina, F., Czapla, J. A., Lawless, A. R., Bongiovanni, E., Santaniello, U., Zappi, H., Dulak, D., Williamson, A., Lee, R., Gupta, A., Li, C., Si, L., Ubaldi, M., Yamazaki, N., Ogata, D., Johnson, R., Park, B. C., Jung, S., Madonna, G., Hochherz, J., Umeda, Y., Nakamura, Y., Gebhardt, C., Festino, L., Capone, M., Ascierto, P. A., Johnson, D. B., Lo, S. N., Long, G. V., Menzies, A. M., Namikawa, K., Mandala, M., Guo, J., Lorigan, P., Najjar, Y. G., Haydon, A., Quaglino, P., Boland, G. M., Sullivan, R. J., Furness, A. J. S., Plummer, R. & Flaherty, K. T., 05.2024, In: ECLINICALMEDICINE. 71, p. 102564

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  5. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy

    Kött, J., Zimmermann, N., Zell, T., Rünger, A., Heidrich, I., Geidel, G., Smit, D. J., Hansen, I., Abeck, F., Schadendorf, D., Eggermont, A., Puig, S., Hauschild, A. & Gebhardt, C., 05.2024, In: EUR J CANCER. 202, 113989.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  6. High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy

    Kött, J., Hoehne, I., Heidrich, I., Zimmermann, N., Reese, K-L., Zell, T., Geidel, G., Rünger, A. M., Schneider, S., Pantel, K., Smit, D. J. & Gebhardt, C., 29.04.2024, In: CANCERS. 16, 9, 1737.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Age matters: Rethinking SLNB's reliability in melanoma mortality prediction

    Gebhardt, C., 04.2024, In: J EUR ACAD DERMATOL. 38, 4, p. 639-640 2 p.

    Research output: SCORING: Contribution to journal › Comment/debate › Research

  8. Erfolgreiche Behandlung eines Checkpoint‐Inhibitor‐assoziierten bullösen Pemphigoids mit Dupilumab bei Angiosarkom

    Hansen, I., Gebhardt, C., Booken, N. & Schneider, S. W., 04.2024, In: J DTSCH DERMATOL GES. 22, 4, p. 587-590 4 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  9. Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma

    Hansen, I., Gebhardt, C., Booken, N. & Schneider, S. W., 04.2024, In: J DTSCH DERMATOL GES. 22, 4, p. 587-589 3 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  10. Successful treatment of refractory checkpoint inhibitor-induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab

    Hansen, I. P. M., Kött, J., Heidenreich, S., Ayuk, F. A., Doll, P. M., Abeck, F., Booken, N., Gebhardt, C. & Schneider, S., 01.03.2024, In: Journal of the European Academy of Dermatology and Venerology Clinical Practice. 3, 1, p. 317-320 4 p.

    Research output: SCORING: Contribution to journal › Case report › Research › peer-review

  11. 2023

  12. Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma

    Geidel, G., Adam, L., Rünger, A., Menz, A., Kött, J., Haalck, T. & Gebhardt, C., 12.2023, In: J EUR ACAD DERMATOL. 37, 12, p. e1414-e1416

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  13. Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study

    Bai, X., Shaheen, A., Grieco, C., d'Arienzo, P. D., Mina, F., Czapla, J. A., Lawless, A. R., Bongiovanni, E., Santaniello, U., Zappi, H., Dulak, D., Williamson, A., Lee, R., Gupta, A., Li, C., Si, L., Ubaldi, M., Yamazaki, N., Ogata, D., Johnson, R., Park, B. C., Jung, S., Madonna, G., Hochherz, J., Umeda, Y., Nakamura, Y., Gebhardt, C., Festino, L., Capone, M., Ascierto, P. A., Johnson, D. B., Lo, S. N., Long, G. V., Menzies, A. M., Namikawa, K., Mandala, M., Guo, J., Lorigan, P., Najjar, Y. G., Haydon, A., Quaglino, P., Boland, G. M., Sullivan, R. J., Furness, A. J. S., Plummer, R. & Flaherty, K. T., 11.2023, In: ECLINICALMEDICINE. 65, p. 102290

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp

    Hassel, J. C., Berking, C., Forschner, A., Gebhardt, C., Heinzerling, L., Meier, F., Ochsenreither, S., Siveke, J., Hauschild, A. & Schadendorf, D., 09.2023, In: EUR J CANCER. 191, p. 112986

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG

    Haist, M., Stege, H., Rogall, F., Tan, Y., von Wasielewski, I., Klespe, K. C., Meier, F., Mohr, P., Kähler, K. C., Weichenthal, M., Hauschild, A., Schadendorf, D., Ugurel, S., Lodde, G., Zimmer, L., Gutzmer, R., Debus, D., Schilling, B., Kreuter, A., Ulrich, J., Meiss, F., Herbst, R., Forschner, A., Leiter, U., Pfoehler, C., Kaatz, M., Ziller, F., Hassel, J. C., Tronnier, M., Sachse, M., Dippel, E., Terheyden, P., Berking, C., Heppt, M. V., Kiecker, F., Haferkamp, S., Gebhardt, C., Simon, J. C., Grabbe, S. & Loquai, C., 09.2023, In: J IMMUNOTHER CANCER. 11, 9, e007630.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG

    Zaremba, A., Mohr, P., Gutzmer, R., Meier, F., Pföhler, C., Weichenthal, M., Terheyden, P., Forschner, A., Leiter, U., Ulrich, J., Utikal, J., Welzel, J., Kaatz, M., Gebhardt, C., Herbst, R., Sindrilaru, A., Dippel, E., Sachse, M., Meiss, F., Heinzerling, L., Haferkamp, S., Weishaupt, C., Löffler, H., Kreft, S., Griewank, K., Livingstone, E., Schadendorf, D., Ugurel, S. & Zimmer, L., 07.2023, In: EUR J CANCER. 188, p. 140-151 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors

    Stadler, J-C., Keller, L., Mess, C., Bauer, A. T., Koett, J., Geidel, G., Heidrich, I., Vidal-Y-Sy, S., Andreas, A., Stramaglia, C., Sementsov, M., Haberstroh, W., Deitert, B., Hoehne, I. L., Reschke, R., Haalck, T., Pantel, K., Gebhardt, C. & Schneider, S. W., 05.2023, In: J IMMUNOTHER CANCER. 11, 5, e006456.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Successful Treatment of PD-1 Inhibitor-induced Psoriasis with Infliximab

    Hansen, I., Heidrich, I., Abeck, F., Kött, J., Booken, N., Gebhardt, C. & Schneider, S. W., 05.2023, In: J EUR ACAD DERMATOL. 37, 5, p. e621-e623

    Research output: SCORING: Contribution to journal › Letter › Research

  19. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

    Franklin, C., Mohr, P., Bluhm, L., Meier, F., Garzarolli, M., Weichenthal, M., Kähler, K., Grimmelmann, I., Gutzmer, R., Utikal, J., Terheyden, P., Herbst, R., Haferkamp, S., Pfoehler, C., Forschner, A., Leiter, U., Ziller, F., Meiss, F., Ulrich, J., Kreuter, A., Gebhardt, C., Welzel, J., Schilling, B., Kaatz, M., Scharfetter-Kochanek, K., Dippel, E., Nashan, D., Sachse, M., Weishaupt, C., Löffler, H., Gambichler, T., Loquai, C., Heinzerling, L., Grabbe, S., Debus, D., Schley, G., Hassel, J. C., Weyandt, G., Trommer, M., Lodde, G., Placke, J-M., Zimmer, L., Livingstone, E., Becker, J. C., Horn, S., Schadendorf, D. & Ugurel, S., 04.2023, In: J IMMUNOTHER CANCER. 11, 4, e005828.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Status quo und Zukunftsperspektiven der molekularen Diagnostik in der Dermatologie

    Gebhardt, C., Eyerich, K. & Garzorz-Stark, N., 04.2023, In: J DTSCH DERMATOL GES. 21, 4, p. 415-419 5 p.

    Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

  21. 2022

  22. Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma

    Ammann, N. L., Schwietzer, Y. F., Mess, C., Stadler, J-C., Geidel, G., Kött, J., Pantel, K., Schneider, S. W., Utikal, J., Bauer, A. T. & Gebhardt, C., 18.11.2022, In: CANCERS. 14, 22, 5676.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry

    Haist, M., Stege, H., Lang, B. M., Tsochataridou, A., Salzmann, M., Mohr, P., Schadendorf, D., Ugurel, S., Placke, J-M., Weichenthal, M., Gutzmer, R., Leiter, U., Kaatz, M., Haferkamp, S., Berking, C., Heppt, M., Tschechne, B., Schummer, P., Gebhardt, C., Grabbe, S. & Loquai, C., 11.11.2022, In: CANCERS. 14, 22, 5543.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients

    DeTemple, V. K., Hassel, J. C., Sachse, M. M., Grimmelmann, I., Leiter, U., Gebhardt, C., Eckardt, J., Pföhler, C., Angela, Y., Hübbe, H. & Gutzmer, R., 07.11.2022, In: CANCERS. 14, 21, 5469.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Immune checkpoint blockade for organ-transplant recipients with cancer: A review

    Rünger, A., Schadendorf, D., Hauschild, A. & Gebhardt, C., 11.2022, In: EUR J CANCER. 175, p. 326-335 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  26. Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG

    Glutsch, V., Schummer, P., Kneitz, H., Gesierich, A., Goebeler, M., Klein, D., Posch, C., Gebhardt, C., Haferkamp, S., Zimmer, L., Becker, J. C., Leiter, U., Weichenthal, M., Schadendorf, D., Ugurel, S. & Schilling, B., 11.2022, In: J IMMUNOTHER CANCER. 10, 11, e005930.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Meeting Report: 47th Annual Meeting of the "Arbeitsgemeinschaft Dermatologische Forschung"

    Stary, G., Fabri, M., Gebhardt, C., Eming, R., Matthias, J., Vorobyev, A., Effern, M., Strobl, J., Günther, C., Zielinski, C., Dudziak, D., Géraud, C., Raker, V., Butze, M., Zhao, F., Wang, Y., Gerloff, D., Bertschi, N. L., Gaffal, E. & Buhl, T., 10.2022, In: EXP DERMATOL. 31, 10, p. 1641-1651 11 p.

    Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

  28. Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives

    Heppt, M. V., Gebhardt, C., Hassel, J. C., Alter, M., Gutzmer, R., Leiter, U. & Berking, C., 20.09.2022, In: CANCERS. 14, 19, 4547.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  29. Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels

    Liu, X., Wang, Y., Bauer, A. T., Kirschfink, M., Ding, P., Gebhardt, C., Borsig, L., Tüting, T., Renné, T., Häffner, K., Hu, W., Schneider, S. W. & Gorzelanny, C., 16.08.2022, In: P NATL ACAD SCI USA. 119, 33, e2122716119.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma

    Geidel, G., Heidrich, I., Kött, J., Schneider, S. W., Pantel, K. & Gebhardt, C., 23.03.2022, In: NPJ PRECIS ONCOL. 6, 1, 17.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  31. Molecular diagnostics in dermatology

    Tizek, L., Schuster, B., Gebhardt, C., Reich, K., von Kiedrowski, R., Biedermann, T., Eyerich, K., Zink, A. & Garzorz-Stark, N., 03.2022, In: J DTSCH DERMATOL GES. 20, 3, p. 287-295 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Current and future clinical applications of ctDNA in immuno-oncology

    Stadler, J. C., Belloum, Y., Deitert, B., Sementsov, M., Heidrich, I., Gebhardt, C., Keller, L. & Pantel, K., 01.02.2022, In: CANCER RES. 82, 3, p. 349-358 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  33. Interplay between coagulation and inflammation in cancer: Limitations and therapeutic opportunities

    Bauer, A. T., Gorzelanny, C., Gebhardt, C., Pantel, K. & Schneider, S. W., 01.2022, In: CANCER TREAT REV. 102, 102322.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  34. Value of cemiplimab in progressive metastatic cutaneous squamous cell carcinoma after kidney transplantation: a case report

    Geidel, G., Rünger, A., Schneider, S. W. & Gebhardt, C., 01.2022, In: J EUR ACAD DERMATOL. 36, S1, p. 49-52 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care - a Randomized Pilot Study

    Ullrich, A., Wilde, S., Müller, V., Sinn, M., Gebhardt, C., Velthaus, J-L., Gerlach, C., Bokemeyer, C. & Oechsle, K., 2022, In: ONCOL RES TREAT. 45, 3, p. 118-129 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. 2021

  37. Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma: Can We Thus Overcome Its High Resistance?

    Blomen, C. L., Kött, J., Hartung, T. I., Torster, L. K. & Gebhardt, C., 20.12.2021, In: CANCERS. 13, 24, 6390.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East

    Ascierto, P. A., Orlova, K., Grignani, G., Dudzisz-Śledź, M., Fenig, E., Chiarion Sileni, V., Fazio, N., Samimi, M., Mortier, L., Gebhardt, C., Kramkimel, N., Steven, N., Bechter, O., Arance, A., Benincasa, E., Kostkova, L., Costa, N. & Lorigan, P., 01.12.2021, In: INT J CANCER. 149, 11, p. 1926-1934 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma

    Nathan, P., Hassel, J. C., Rutkowski, P., Baurain, J-F., Butler, M. O., Schlaak, M., Sullivan, R. J., Ochsenreither, S., Dummer, R., Kirkwood, J. M., Joshua, A. M., Sacco, J. J., Shoushtari, A. N., Orloff, M., Piulats, J. M., Milhem, M., Salama, A. K. S., Curti, B., Demidov, L., Gastaud, L., Mauch, C., Yushak, M., Carvajal, R. D., Hamid, O., Abdullah, S. E., Holland, C., Goodall, H., Piperno-Neumann, S. & IMCgp100-202 Investigators, 23.09.2021, In: NEW ENGL J MED. 385, 13, p. 1196-1206 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Adjuvante Pembrolizumab-assoziierte Hyperprogression eines Melanoms im Stadium III

    Ammann, N. L., Geidel, G., Schneider, S. W. & Gebhardt, C., 09.2021, In: J DTSCH DERMATOL GES. 19, 9, p. 1341-1345 5 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  41. Adjuvant pembrolizumab-related hyperprogression in stage III melanoma

    Ammann, N. L., Geidel, G., Schneider, S. W. & Gebhardt, C., 09.2021, In: J DTSCH DERMATOL GES. 19, 9, p. 1341-1345 5 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  42. 47. Jahrestagung der „Arbeitsgemeinschaft Dermatologische Forschung“ (ADF)

    Gaffal, E., Eming, R., Fabri, M., Gebhardt, C., Stary, G. & Buhl, T., 08.2021, In: J DTSCH DERMATOL GES. 19, 8, p. 1253-1254 2 p.

    Research output: SCORING: Contribution to journal › Conference article in journal › Research › peer-review

  43. Hyperprogression fortgeschrittener Melanomerkrankung unter Pembrolizumab adjuvant

    Geidel, G., Ammann, N. L., Schneider, S. W. & Gebhardt, C., 07.2021, In: J DTSCH DERMATOL GES. 19, S1, p. 37-39 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis

    Loreth, D., Schuette, M., Zinke, J., Mohme, M., Piffko, A., Schneegans, S., Stadler, J., Janning, M., Loges, S., Joosse, S. A., Lamszus, K., Westphal, M., Müller, V., Glatzel, M., Matschke, J., Gebhardt, C., Schneider, S. W., Belczacka, I., Volkmer, B., Greinert, R., Yaspo, M-L., Harter, P. N., Pantel, K. & Wikman, H., 29.06.2021, In: INT J MOL SCI. 22, 13, 6993.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

    Steeb, T., Wessely, A., Alter, M., Bayerl, C., Bender, A., Bruning, G., Dabrowski, E., Debus, D., Devereux, N., Dippel, E., Drexler, K., Dücker, P., Dummer, R., Emmert, S., Elsner, P., Enk, A., Gebhardt, C., Gesierich, A., Goebeler, M., Goerdt, S., Goetze, S., Gutzmer, R., Haferkamp, S., Hansel, G., Hassel, J. C., Heinzerling, L., Kähler, K. C., Kaume, K. M., Krapf, W., Kreuzberg, N., Lehmann, P., Livingstone, E., Löffler, H., Loquai, C., Mauch, C., Mangana, J., Meier, F., Meissner, M., Moritz, R. K. C., Maul, L. V., Müller, V., Mohr, P., Navarini, A., Van Nguyen, A., Pfeiffer, C., Pföhler, C., Posch, C., Richtig, E., Rompel, R., Sachse, M. M., Sauder, S., Schadendorf, D., Schatton, K., Schulze, H-J., Schultz, E., Schilling, B., Schmuth, M., Simon, J. C., Streit, M., Terheyden, P., Thiem, A., Tüting, T., Welzel, J., Weyandt, G., Wesselmann, U., Wollina, U., Ziemer, M., Zimmer, L., Zutt, M., Berking, C., Schlaak, M., Heppt, M. V. & Dermatologic Cooperative Oncology Group (DeCOG), 06.2021, In: J CANCER RES CLIN. 147, 6, p. 1763-1771 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients

    Lodde, G., Forschner, A., Hassel, J., Wulfken, L. M., Meier, F., Mohr, P., Kähler, K., Schilling, B., Loquai, C., Berking, C., Hüning, S., Schatton, K., Gebhardt, C., Eckardt, J., Gutzmer, R., Reinhardt, L., Glutsch, V., Nikfarjam, U., Erdmann, M., Stang, A., Kowall, B., Roesch, A., Ugurel, S., Zimmer, L., Schadendorf, D. & Livingstone, E., 12.05.2021, In: CANCERS. 13, 10, 2319.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study

    Wagner, N. B., Lenders, M. M., Kühl, K., Reinhardt, L., André, F., Dudda, M., Ring, N., Ebel, C., Stäger, R., Zellweger, C., Lang, R., Paar, M., Gussek, P., Richtig, G., Stürmer, S. H., Kimeswenger, S., Oellinger, A., Forschner, A., Leiter, U., Weide, B., Gassenmaier, M., Schraag, A., Klumpp, B., Hoetzenecker, W., Berking, C., Richtig, E., Ziemer, M., Mangana, J., Terheyden, P., Loquai, C., Nguyen, V. A., Gebhardt, C., Meier, F., Diem, S., Cozzio, A., Flatz, L., Röcken, M., Garbe, C. & Eigentler, T. K., 05.2021, In: J IMMUNOTHER CANCER. 9, 5, e002350.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study

    Gebhardt, C., Simon, S. C. S., Weber, R., Gries, M., Mun, D. H., Reinhard, R., Holland-Letz, T., Umansky, V. & Utikal, J., 02.2021, In: CELL IMMUNOL. 360, p. 104274 104274.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology group

    Wessely, A., Steeb, T., Berking, C., Schlaak, M., Heppt, M. V. & Dermatologic Cooperative Oncology Group (DeCOG), 01.2021, In: EUR J CANCER. 143, p. 43-45 3 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  50. 2020

  51. The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitions

    Gebhardt, C., Ascierto, P., Atkinson, V., Corrie, P., Dummer, R. & Schadendorf, D., 10.2020, In: EUR J CANCER. 138, p. 68-76 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients

    Schneegans, S., Lück, L., Besler, K., Bluhm, L., Stadler, J-C., Staub, J., Greinert, R., Volkmer, B., Kubista, M., Gebhardt, C., Sartori, A., Irwin, D., Serkkola, E., Af Hällström, T., Lianidou, E., Sprenger-Haussels, M., Hussong, M., Mohr, P., Schneider, S. W., Shaffer, J., Pantel, K. & Wikman, H., 05.2020, In: MOL ONCOL. 14, 5, p. 1001-1015 15 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. 2019

  54. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target

    Orouji, E., Federico, A., Larribère, L., Novak, D., Lipka, D. B., Assenov, Y., Sachindra, S., Hüser, L., Granados, K., Gebhardt, C., Plass, C., Umansky, V. & Utikal, J., 15.12.2019, In: INT J CANCER. 145, 12, p. 3462-3477 16 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC.

    Plasmeijer, EI., Sachse, MM., Gebhardt, C., Geusau, A. & Bouwes, B. JN., 12.2019, In: J EUR ACAD DERMATOL. 33, 58, p. 33-37

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  56. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

    Wagner, NB., Weide, B., Gries, M., Reith, M., Tarnanidis, K., Schuermans, V., Kemper, C., Kehrel, C., Funder, A., Lichtenberger, R., Sucker, A., Herpel, E., Holland-Letz, T. & Gebhardt, C., 12.2019, In: J IMMUNOTHER CANCER. 2019, 7, 343.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next